Effects of physical activity training in patients with Alzheimer's dementia: results of a pilot RCT study

PLoS One. 2015 Apr 17;10(4):e0121478. doi: 10.1371/journal.pone.0121478. eCollection 2015.

Abstract

Background: There is evidence that physical activity (PA) is of cognitive benefit to the ageing brain, but little is known on the effect in patients with Alzheimer's disease (AD). The present pilot study assessed the effect of a home-based PA training on clinical symptoms, functional abilities, and caregiver burden after 12 and 24 weeks.

Methods: In an RCT thirty patients (aged 72.4±4.3 years) with AD (MMSE: 20.6±6.5 points) and their family caregivers were allocated to a home-based 12-week PA intervention program or the usual care group. The program changed between passive, motor-assisted or active resistive leg training and changes in direction on a movement trainer in order to combine physical and cognitive stimuli.

Results: Analysis of activities of daily living in the patients (ADCS ADL total score) revealed a significant group × time interaction effect (95% CI of the difference between both groups at T2: 5.01-10.51). The control group experienced decreases in ADL performance at week 12 and 24 whereas patients in the intervention group remained stable. Analyses of executive function and language ability revealed considerable effects for semantic word fluency with a group × time interaction (95% CI of the difference between both groups at T2: 0.18-4.02). Patients in the intervention group improved during the intervention and returned to initial performance at week 12 whereas the controls revealed continuous worsening. Analyses of reaction time, hand-eye quickness and attention revealed improvement only in the intervention group. Caregiver burden remained stable in the intervention group but worsened in the control group.

Conclusions: This study suggests that PA in a home-based setting might be an effective and intrinsically attractive way to promote PA training in AD and modulate caregiver burden. The results demonstrate transfer benefits to ADL, cognitive and physical skill in patients with AD.

Trial registration: ClinicalTrials.gov NCT02196545.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activities of Daily Living
  • Aged
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / physiopathology*
  • Behavior Therapy / methods*
  • Caregivers / psychology
  • Cholinesterase Inhibitors / therapeutic use
  • Demography
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Motor Activity*
  • Pilot Projects
  • Program Evaluation

Substances

  • Cholinesterase Inhibitors

Associated data

  • ClinicalTrials.gov/NCT02196545

Grants and funding

Sponsor: RECK-Technik GmbH & Co. KG (Betzenweiler, Germany) provided all movement trainers (ReckMOTOmed viva2®), technical support and delivery to and from the participants’ homes. There was no financial sponsoring or scientific contribution by the sponsor. The sponsor is acknowledged in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other current funding sources for this study.